{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:13:44Z","timestamp":1790118824569,"version":"4.0.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"52","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,1]]},"DOI":"10.1093\/jncimonographs\/lgx007","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T19:12:08Z","timestamp":1502997128000},"source":"Crossref","is-referenced-by-count":9,"title":["US National Cancer Institute\u2013China Collaborative Studies on Chinese Medicine and Cancer"],"prefix":"10.1093","volume":"2017","author":[{"given":"Libin","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Oppenheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. M. Zack","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiting","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Colburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry R.","family":"O\u2019Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Beutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jikai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,11,13]]},"reference":[{"key":"key\n\t\t\t\t20171112190727_lgx007-B1","first-page":"1","year":"2006"},{"key":"key\n\t\t\t\t20171112190727_lgx007-B2","first-page":"931","article-title":"Multi-center randomized clinical study on Shengqi-fuzheng injection combined with chemotherapy in the treatment for lung cancer","volume":"12","year":"2007","journal-title":"Chin J Oncol."},{"key":"key\n\t\t\t\t20171112190727_lgx007-B3"},{"key":"key\n\t\t\t\t20171112190727_lgx007-B4"},{"key":"key\n\t\t\t\t20171112190727_lgx007-B5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.canlet.2014.08.037","article-title":"Fufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathways","volume":"355","year":"2014","journal-title":"Cancer Lett."},{"key":"key\n\t\t\t\t20171112190727_lgx007-B6","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/mc.22179","article-title":"Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice","volume":"54","year":"2015","journal-title":"Mol Carcinog."},{"key":"key\n\t\t\t\t20171112190727_lgx007-B7","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.18632\/oncotarget.3629","article-title":"Targeting AMPK for cancer prevention and treatment","volume":"6","year":"2015","journal-title":"Oncotarget."},{"key":"key\n\t\t\t\t20171112190727_lgx007-B8","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1093\/carcin\/bgu209","article-title":"Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression","volume":"35","year":"2014","journal-title":"Carcinogenesis."},{"key":"key\n\t\t\t\t20171112190727_lgx007-B9","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.3892\/ol.2016.4444","article-title":"Cryptotanshinone targets tumor-initiating cells through down-regulation of stemness genes expression","volume":"11","year":"2016","journal-title":"Oncol Lett."},{"key":"key\n\t\t\t\t20171112190727_lgx007-B10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11010-015-2424-0","article-title":"Cryptotanshinone, a Stat3 inhibitor, suppresses colorectal cancer proliferation and growth in vitro","volume":"406","year":"2015","journal-title":"Mol Cell Biochem."},{"key":"key\n\t\t\t\t20171112190727_lgx007-B11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumor cell line anticancer drug screen","volume":"6","year":"2006","journal-title":"Nat Rev Cancer."},{"issue":"3","key":"key\n\t\t\t\t20171112190727_lgx007-B12","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbrc.2009.10.045","article-title":"Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: Cross-talk between E3s in the endoplasmic reticulum","volume":"390","year":"2009","journal-title":"Biochem Biophys Res Commun."},{"key":"key\n\t\t\t\t20171112190727_lgx007-B13","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nsmb.1628","article-title":"Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1","volume":"16","year":"2009","journal-title":"Nat Struct Mol Biol."},{"key":"key\n\t\t\t\t20171112190727_lgx007-B14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1177\/1087057108321085","article-title":"Novel dual-reporter preclinical screen for anti-astrocytoma agents identifies cytostatic and cytotoxic compounds","volume":"13","year":"2008","journal-title":"J Biomol Screen."},{"key":"key\n\t\t\t\t20171112190727_lgx007-B15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/cbdd.12146","article-title":"High-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells","volume":"82","year":"2013","journal-title":"Chem Biol Drug Des."},{"key":"key\n\t\t\t\t20171112190727_lgx007-B16","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ccr.2012.11.011","article-title":"A new \u201cbrew\u201d of MALT1 inhibitors","volume":"22","year":"2012","journal-title":"Cancer Cell."},{"key":"key\n\t\t\t\t20171112190727_lgx007-B17","doi-asserted-by":"crossref","first-page":"29469","DOI":"10.18632\/oncotarget.5177","article-title":"Characterization of the metastatic phenotype of a panel of established osteosarcoma cells","volume":"6","year":"2015","journal-title":"Oncotarget."},{"key":"key\n\t\t\t\t20171112190727_lgx007-B18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.chembiol.2013.04.001","article-title":"An electrophoretic mobility shift assay identifies a mechanistically unique inhibitor of protein sumoylation","volume":"20","year":"2013","journal-title":"Chem Biol."},{"key":"key\n\t\t\t\t20171112190727_lgx007-B19","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00262-008-0637-8","article-title":"A cell-based high-throughput screen to identify synergistic TRAIL sensitizers","volume":"58","year":"2009","journal-title":"Cancer Immunol Immunother."},{"key":"key\n\t\t\t\t20171112190727_lgx007-B20","first-page":"277","article-title":"Discovery and characterization of a biologically active non-ATP-competitive p38 MAP kinase inhibitor","volume":"21","year":"2015","journal-title":"J Biomol Screen."},{"key":"key\n\t\t\t\t20171112190727_lgx007-B21","first-page":"1","article-title":"Proceedings of the strategy meeting for the development of an International Consortium for Chinese Medicine and Cancer","volume":"005710","year":"2016","journal-title":"J Global Oncol."}],"container-title":["JNCI Monographs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jncimono\/article-pdf\/2017\/52\/lgx007\/21697216\/lgx007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T14:26:07Z","timestamp":1570026367000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jncimono\/article\/doi\/10.1093\/jncimonographs\/lgx007\/4617822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":21,"journal-issue":{"issue":"52","published-online":{"date-parts":[[2017,11,13]]},"published-print":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jncimonographs\/lgx007","relation":{},"ISSN":["1052-6773","1745-6614"],"issn-type":[{"value":"1052-6773","type":"print"},{"value":"1745-6614","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11]]},"published":{"date-parts":[[2017,11,1]]}}}